Skip to main content
Clinical Trials/NCT03090386
NCT03090386CompletedNot Applicable

Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

Mayo Clinic1 site in 1 country30 target enrollmentStarted: February 25, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Cognitive Communication Survey

Study Overview

Brief Summary

This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 89 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • be between18 to 89 years old;
  • have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery)
  • have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study;
  • be native speakers of American English;
  • have obtained a minimum of a high school education;
  • self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; and
  • must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool.

Exclusion Criteria

  • are younger than 18 years old or older than 89 years old;
  • have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery)
  • have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment;
  • are not native speakers of American English;
  • have not obtained a minimum of a high school education;
  • do not self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; or
  • do not demonstrate the capacity to sign informed consent

Outcomes

Primary Outcomes

Cognitive Communication Survey

Time Frame: 1 day at time of consent

Survey is completed at time of consent

Secondary Outcomes

  • Cognitive-linguistic Standardized Testing(within 3 months of cognitive communication survey)
  • Follow-up Survey(within 6 months after completion of standardized testing)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nadia N. Laack, M.D.

PI

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials

Evaluation of Cognitive-Communication... | Clinical Trial